Sub-category 8.2 - Drugs affecting the immune response
Alemtuzumab in chronic lymphocytic leukaemia
Evaluation report
Mar 07
Fingolimod
New Drug Evaluation
110
May 11
Natalizumab in multiple sclerosis (N)
Rituximab in combination with cvp chemotherapy for the management of follicular non-hodgkin’s lymphoma
Mar 06
Home | About us | Management | Publications | Education | Services | Links | Contact us | Search
RSS Feed
Site last updated 03/02/2012
